Received Apr 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 9PT2F | — |
Infanrix expired dose administration; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 9-month-old female patient who received DTPa (Infanrix) (batch number 9PT2F, expiry date 10-MAR-2026) for prophylaxis. On 31-MAR-2026, the patient received Infanrix. On 31-MAR-2026, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: Infanrix expired dose administration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-MAR-2026 The healthcare provider wanted to know how to proceed with a patient who had received an expired dose of Infanrix on 31-MAR-2026 with expiry date 10-MAR-2026.